Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | BCHE | P06276 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6115226 | 0.98 | CA1 (0.40) | CA1CA2CYP2D6CYP3A4CYP2C19 | |
| SCHEMBL6115185 | 0.94 | CA1 (0.37) | CA1CA2CYP2D6CYP3A4CYP2C19 | |
| SCHEMBL869647 | 0.90 | SIGMAR1 (0.41) | CA1CA2POLB | |
| Hydrochloric Acid SCHEMBL5835817 | 0.88 | SIGMAR1 (0.40) | CA1CA2POLB | |
| SCHEMBL21314162 | 0.84 | SIGMAR1 (0.37) | CA1CA2POLB | |
| SCHEMBL667064 | 0.81 | CHKA (0.46) | CA1CA2POLBKMT2AATM | |
| SCHEMBL21314160 | 0.81 | POLB (0.40) | POLBKMT2A | |
| SCHEMBL1076866 | 0.81 | KMT2A (0.42) | CA1CA2CYP2D6POLBKMT2A | |
| Hydrochloric Acid SCHEMBL382999 | 0.80 | ALDH1A1 (0.46) | CA1CA2POLBKMT2AATM | |
| Water SCHEMBL31529761 | 0.80 | CHKA (0.44) | CA1CA2POLBKMT2AATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2252672-B1 | COMPOSITION COMPRISING PHOTOCHROMIC DYES IN AN IONIC SOLVENT | ESSILOR INT (FR) | 2019-02-20 | — | — | EP | claimed |
| EP-2252672-A2 | COMPOSITION COMPRISING PHOTOCHROMIC DYES IN AN IONIC SOLVENT | Essilor International (Compagnie Générale D'Optique) (FR) | 2010-11-24 | — | — | EP | claimed |
| WO-2009115721-A2 | COMPOSITION COMPRISING PHOTOCHROMIC DYES IN AN IONIC SOLVENT | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2009-09-24 | — | — | WO | claimed |
| EP-2252672-B1 | COMPOSITION COMPRISING PHOTOCHROMIC DYES IN AN IONIC SOLVENT | ESSILOR INT (FR) | 2019-02-20 | — | — | EP | disclosed |
| EP-2474527-B1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | WAKO PURE CHEM IND LTD (JP) | 2017-01-25 | — | — | EP | disclosed |
| US-8546609-B2 | Ionic liquid containing allylsulfonate anion | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-10-01 | — | — | US | disclosed |
| US-8411347-B2 | Composition comprising photochromic dyes in an ionic solvent | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2013-04-02 | — | — | US | disclosed |
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
| US-20110013252-A1 | COMPOSITION COMPRISING PHOTOCHROMIC DYES IN AN IONIC SOLVENT | Essilor International (compagnie Generale D'optiqu e (FR) | 2011-01-20 | — | — | US | disclosed |
| EP-2252672-A2 | COMPOSITION COMPRISING PHOTOCHROMIC DYES IN AN IONIC SOLVENT | Essilor International (Compagnie Générale D'Optique) (FR) | 2010-11-24 | — | — | EP | disclosed |
| WO-2009115721-A2 | COMPOSITION COMPRISING PHOTOCHROMIC DYES IN AN IONIC SOLVENT | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2009-09-24 | — | — | WO | disclosed |
| US-7504542-B2 | Preparation of α-hydroxy ketones via carbene-catalyzed umpolung reaction of aldehydes | EVONIK DEGUSSA GMBH (DE) | 2009-03-17 | — | — | US | disclosed |
| US-7504542-B2 | Preparation of α-hydroxy ketones via carbene-catalyzed umpolung reaction of aldehydes | EVONIK DEGUSSA GMBH (DE) | 2009-03-17 | — | — | US | disclosed |
| US-20080051608-A1 | Preparation of alpha-hydroxy ketones via carbene-catalyzed umpolung reaction of aldehydes | DEGUSSA GMBH (DE) | 2008-02-28 | — | — | US | disclosed |
| US-20080051608-A1 | Preparation of alpha-hydroxy ketones via carbene-catalyzed umpolung reaction of aldehydes | DEGUSSA GMBH (DE) | 2008-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080051608-A1 | Preparation of alpha-hydroxy ketones via carbene-catalyzed umpolung reaction of aldehydes | HACL2, PCCA, ECI1 | CA1 4286/4885CA2 4165/4885CYP2D6 414/4885 |
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | ATXN2L, ARL1, INPPL1 | CA1 2316/4885CA2 666/4885CYP2D6 3554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.